181 related articles for article (PubMed ID: 32076440)
1.
Liu W; Pan HF; Yang LJ; Zhao ZM; Yuan DS; Liu YL; Lin LZ
Evid Based Complement Alternat Med; 2020; 2020():2672648. PubMed ID: 32076440
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Weipixiao decoction against MNNG-induced gastric precancerous lesions in rats.
Cai T; Zhang C; Zeng X; Zhao Z; Yan Y; Yu X; Wu L; Lin L; Pan H
Biomed Pharmacother; 2019 Dec; 120():109427. PubMed ID: 31648165
[TBL] [Abstract][Full Text] [Related]
3. Weipiling ameliorates gastric precancerous lesions in Atp4a
Liu W; Zhao ZM; Liu YL; Pan HF; Lin LZ
BMC Complement Altern Med; 2019 Nov; 19(1):318. PubMed ID: 31744486
[TBL] [Abstract][Full Text] [Related]
4. Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells.
Zhang JX; Bao SC; Chen J; Chen T; Wei HL; Zhou XY; Li JT; Yan SG
World J Gastrointest Oncol; 2023 Mar; 15(3):464-489. PubMed ID: 37009319
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions.
Lv S; Chen X; Chen Y; Gong D; Mao G; Shen C; Xia T; Cheng J; Luo Z; Cheng Y; Li W; Zeng J
BMC Complement Med Ther; 2022 Jul; 22(1):188. PubMed ID: 35840932
[TBL] [Abstract][Full Text] [Related]
6. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
Cai T; Zhang C; Zhao Z; Li S; Cai H; Chen X; Cai D; Liu W; Yan Y; Xie K; Pan H; Zeng X
Biomed Pharmacother; 2018 Aug; 104():291-299. PubMed ID: 29775897
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4.
Zeng Z; Nian Q; Chen N; Zhao M; Zheng Q; Zhang G; Zhao Z; Chen Y; Wang J; Zeng J; Gong D; Tang J
Biomed Pharmacother; 2022 Jan; 145():112086. PubMed ID: 34799220
[TBL] [Abstract][Full Text] [Related]
8. 20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K/AKT pathway-mediated inflammation and apoptosis.
Zhou YD; Hou JG; Liu W; Ren S; Wang YP; Zhang R; Chen C; Wang Z; Li W
Int Immunopharmacol; 2018 Jun; 59():21-30. PubMed ID: 29621733
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429.
Wang X; He R; Geng L; Yuan J; Fan H
Front Genet; 2022; 13():823182. PubMed ID: 35309116
[TBL] [Abstract][Full Text] [Related]
10. Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions.
Zeng J; Yan R; Pan H; You F; Cai T; Liu W; Zheng C; Zhao Z; Gong D; Chen L; Zhang Y
BMC Complement Altern Med; 2018 Sep; 18(1):250. PubMed ID: 30200948
[TBL] [Abstract][Full Text] [Related]
11. Weiqi Decoction Attenuated Chronic Atrophic Gastritis with Precancerous Lesion through Regulating Microcirculation Disturbance and HIF-1
Yin J; Yi J; Yang C; Xu B; Lin J; Hu H; Wu X; Shi H; Fei X
Evid Based Complement Alternat Med; 2019; 2019():2651037. PubMed ID: 31320912
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway.
Zhang C; Cai T; Zeng X; Cai D; Chen Y; Huang X; Gan H; Zhuo J; Zhao Z; Pan H; Li S
Phytother Res; 2018 Jul; 32(7):1364-1372. PubMed ID: 29577459
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction.
Zeng J; Ma X; Zhao Z; Chen Y; Wang J; Hao Y; Yu J; Zeng Z; Chen N; Zhao M; Tang J; Gong D
Front Pharmacol; 2021; 12():682713. PubMed ID: 34594214
[No Abstract] [Full Text] [Related]
17. Ginsenoside Rg3 Attenuates Lipopolysaccharide-Induced Acute Lung Injury via MerTK-Dependent Activation of the PI3K/AKT/mTOR Pathway.
Yang J; Li S; Wang L; Du F; Zhou X; Song Q; Zhao J; Fang R
Front Pharmacol; 2018; 9():850. PubMed ID: 30116194
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions.
Aziz F; Wang X; Liu J; Yan Q
Toxicol In Vitro; 2016 Mar; 31():158-66. PubMed ID: 26427350
[TBL] [Abstract][Full Text] [Related]
19. Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4.
Gao Y; Wang J; Zhao M; Xia T; Liu Q; Chen N; Liao W; Zeng Z; You F; Zeng J
Front Pharmacol; 2022; 13():797805. PubMed ID: 35846998
[No Abstract] [Full Text] [Related]
20. Ginsenoside Rg3 inhibits the biological activity of SGC-7901.
Yang Q; Cai N; Che D; Chen X; Wang D
Food Sci Nutr; 2020 Aug; 8(8):4151-4158. PubMed ID: 32884696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
